April Layne Kennedy
Physician Assistant at California St, Denver, CO
License number
Colorado 4299
Issued Date
Jun 26, 2015
Renew Date
Feb 1, 2016
Expiration Date
Jan 31, 2018
Type
Physician Assistant
Address
Address
2435 California St, Denver, CO 80205
Professional information
See more information about April Layne Kennedy at trustoria.com
Macrocyclic Compounds As Inhibitors Of Viral Replication
Macrocyclic Compounds As Inhibitors Of Viral Replication
US Patent:
7491794, Feb 17, 2009
Filed:
Mar 29, 2005
Appl. No.:
11/093884
Inventors:
Lawrence M. Blatt - San Francisco CA, US
Steven W. Andrews - Longmont CO, US
Kevin R. Condroski - Broomfield CO, US
Yutong Jiang - Longmont CO, US
April L. Kennedy - Denver CO, US
Peter J. Stengel - Longmont CO, US
Steven M. Wenglowsky - Boulder CO, US
Steven W. Andrews - Longmont CO, US
Kevin R. Condroski - Broomfield CO, US
Yutong Jiang - Longmont CO, US
April L. Kennedy - Denver CO, US
Peter J. Stengel - Longmont CO, US
Steven M. Wenglowsky - Boulder CO, US
Assignee:
Intermune, Inc. - Brisbane CA
International Classification:
A61K 38/12
US Classification:
530317
Abstract:
The embodiments provide compounds of the general formulas I-XIX, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating flaviviral infection, including hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.
Substituted N-(1H-Indazol-4-Yl)Imidazo[1,2-A]Pyridine-3-Carboxamide Compounds As Cfms Inhibitors
Substituted N-(1H-Indazol-4-Yl)Imidazo[1,2-A]Pyridine-3-Carboxamide Compounds As Cfms Inhibitors
US Patent:
2012025, Oct 11, 2012
Filed:
Dec 20, 2010
Appl. No.:
13/517938
Inventors:
Mark Laurence Boys - Boulder CO, US
Michael F. Bradley - Boulder CO, US
Robert Kirk DeLisle - Boulder CO, US
D. David Hennings - Boulder CO, US
April L. Kennedy - Denver CO, US
Fredrik P. Marmsater - Boulder CO, US
Matthew David Medina - Boulder CO, US
Mark C. Munson - Acton MA, US
Bryson Rast - Westminster CO, US
James P. Rizzi - Addison TX, US
Martha E. Rodriguez - Lafayette CO, US
George T. Topalov - Pittsburgh PA, US
Qian Zhao - Louisville CO, US
Michael F. Bradley - Boulder CO, US
Robert Kirk DeLisle - Boulder CO, US
D. David Hennings - Boulder CO, US
April L. Kennedy - Denver CO, US
Fredrik P. Marmsater - Boulder CO, US
Matthew David Medina - Boulder CO, US
Mark C. Munson - Acton MA, US
Bryson Rast - Westminster CO, US
James P. Rizzi - Addison TX, US
Martha E. Rodriguez - Lafayette CO, US
George T. Topalov - Pittsburgh PA, US
Qian Zhao - Louisville CO, US
Assignee:
ARRAY BIOPHARMA INC. - Boulder CO
International Classification:
A61K 31/437, A61K 31/496, A61K 31/5377, A61K 31/4985, A61K 31/541, A61P 25/00, A61P 19/08, A61P 35/00, A61P 37/00, A61P 29/00, A61P 9/00, C07D 471/04, A61K 31/551
US Classification:
51421021, 546121, 514300, 544362, 51425304, 544127, 5142332, 544350, 514249, 544349, 544 582, 5142282, 540575, 514218
Abstract:
Compounds of Formula (I): and pharmaceutically acceptable salts thereof in which R, R, R, Rand Rhave the meanings given in the specification, are inhibitors of cFMS and are useful in the treatment of bone-related diseases, cancer, autoimmune disorders, inflammatory diseases, cardiovascular diseases and pain.
Macrocyclic Inhibitors Of Hepatitis C Virus Replication
Macrocyclic Inhibitors Of Hepatitis C Virus Replication
US Patent:
8299021, Oct 30, 2012
Filed:
Apr 19, 2012
Appl. No.:
13/450885
Inventors:
Lawrence M Blatt - Brisbane CA, US
Scott D Seiwert - Pacifica CA, US
Steven W Andrews - Langmont CO, US
Pierre Martin - Rheinfelden, CH
Andreas Schumacher - Efringen-Kirchen, DE
Bradley Barnett - Northglenn CO, US
C. Todd Eary - Longmont CO, US
Robert Kaus - Longmont CO, US
Timothy Kercher - Boulder CO, US
Weidong Liu - Superior CO, US
Michael Lyon - Superior CO, US
Paul Nichols - Firestone CO, US
Bin Wang - Longmont CO, US
Tarek Sammakia - Boulder CO, US
April Kennedy - Denver CO, US
Yutong Jiang - Longmont CO, US
Scott D Seiwert - Pacifica CA, US
Steven W Andrews - Langmont CO, US
Pierre Martin - Rheinfelden, CH
Andreas Schumacher - Efringen-Kirchen, DE
Bradley Barnett - Northglenn CO, US
C. Todd Eary - Longmont CO, US
Robert Kaus - Longmont CO, US
Timothy Kercher - Boulder CO, US
Weidong Liu - Superior CO, US
Michael Lyon - Superior CO, US
Paul Nichols - Firestone CO, US
Bin Wang - Longmont CO, US
Tarek Sammakia - Boulder CO, US
April Kennedy - Denver CO, US
Yutong Jiang - Longmont CO, US
Assignee:
InterMune, Inc. - Brisbane CA
International Classification:
A61K 38/00
US Classification:
514 37
Abstract:
The embodiments provide compounds of the general Formulae I through general Formula VIII, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.
Novel Inhibitors Of Hepatitis C Virus Replication
Novel Inhibitors Of Hepatitis C Virus Replication
US Patent:
2010020, Aug 19, 2010
Filed:
Apr 28, 2010
Appl. No.:
12/769449
Inventors:
SCOTT SEIWERT - PACIFICA CA, US
LEONID BEIGELMAN - SAN MATEO CA, US
LAWRENCE M. BLATT - SAN FRANCISCO CA, US
TIMOTHY KERCHER - BOULDER CO, US
APRIL L. KENNEDY - DENVER CO, US
STEVEN W. ANDREWS - LONGMONT CO, US
LEONID BEIGELMAN - SAN MATEO CA, US
LAWRENCE M. BLATT - SAN FRANCISCO CA, US
TIMOTHY KERCHER - BOULDER CO, US
APRIL L. KENNEDY - DENVER CO, US
STEVEN W. ANDREWS - LONGMONT CO, US
Assignee:
INTERMUNE, INC. - Brisbane CA
International Classification:
A61K 31/404, C07D 403/12, A61K 31/7052, A61K 31/427, A61K 38/21, A61K 31/7072, A61K 31/7068, A61P 1/16
US Classification:
424 855, 548467, 514414, 514 43, 514365, 424 857, 514 50, 514 49
Abstract:
The embodiments provide compounds of the general Formula II, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments also provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.
Macrocyclic Compounds As Inhibitors Of Viral Replication
Macrocyclic Compounds As Inhibitors Of Viral Replication
US Patent:
2009010, Apr 23, 2009
Filed:
Dec 22, 2008
Appl. No.:
12/341971
Inventors:
Lawrence M. Blatt - San Francisco CA, US
Steven W. Andrews - Longmont CO, US
Kevin R. Condroski - Broomfield CO, US
George A. Doherty - Superior CO, US
Yutong Jiang - Longmont CO, US
John A. Josey - Longmont CO, US
April L. Kennedy - Denver CO, US
Machender R. Madduru - Boulder CO, US
Peter J. Stengel - Longmont CO, US
Steven M. Wenglowsky - Boulder CO, US
Benjamin T. Woodard - Golden CO, US
Laura Woodard - Golden CO, US
Steven W. Andrews - Longmont CO, US
Kevin R. Condroski - Broomfield CO, US
George A. Doherty - Superior CO, US
Yutong Jiang - Longmont CO, US
John A. Josey - Longmont CO, US
April L. Kennedy - Denver CO, US
Machender R. Madduru - Boulder CO, US
Peter J. Stengel - Longmont CO, US
Steven M. Wenglowsky - Boulder CO, US
Benjamin T. Woodard - Golden CO, US
Laura Woodard - Golden CO, US
International Classification:
C07D 225/04, C07D 245/04
US Classification:
540460, 540461
Abstract:
The embodiments provide compounds of the general formulas I-XIX, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating flaviviral infection, including hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.
Macrocyclic Compounds As Inhibitors Of Viral Replication
Macrocyclic Compounds As Inhibitors Of Viral Replication
US Patent:
2009028, Nov 19, 2009
Filed:
Oct 20, 2008
Appl. No.:
12/254736
Inventors:
LAWRENCE M. BLATT - SAN FRANCISCO CA, US
STEVEN W. ANDREWS - LONGMONT CO, US
KEVIN R. CONDROSKI - BROOMFIELD CO, US
GEORGE A. DOHERTY - SUPERIOR CO, US
YUTONG JIANG - LONGMONT CO, US
JOHN A. JOSEY - LONGMONT CO, US
APRIL L. KENNEDY - DENVER CO, US
MACHENDER R. MADDURU - BOULDER CO, US
PETER J. STENGEL - LONGMONT CO, US
STEVEN M. WENGLOWSKY - BOULDER CO, US
BENJAMIN T. WOODARD - GOLDEN CO, US
LAURA WOODARD - GOLDEN CO, US
STEVEN W. ANDREWS - LONGMONT CO, US
KEVIN R. CONDROSKI - BROOMFIELD CO, US
GEORGE A. DOHERTY - SUPERIOR CO, US
YUTONG JIANG - LONGMONT CO, US
JOHN A. JOSEY - LONGMONT CO, US
APRIL L. KENNEDY - DENVER CO, US
MACHENDER R. MADDURU - BOULDER CO, US
PETER J. STENGEL - LONGMONT CO, US
STEVEN M. WENGLOWSKY - BOULDER CO, US
BENJAMIN T. WOODARD - GOLDEN CO, US
LAURA WOODARD - GOLDEN CO, US
International Classification:
A61K 31/407, C07D 245/00, A61P 31/12
US Classification:
514411, 540460
Abstract:
The embodiments provide compounds of the general formulas I-XIX, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating flaviviral infection, including hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.
Macrocyclic Compounds As Inhibitors Of Viral Replication
Macrocyclic Compounds As Inhibitors Of Viral Replication
US Patent:
2009011, Apr 30, 2009
Filed:
Dec 22, 2008
Appl. No.:
12/341683
Inventors:
Lawrence M. Blatt - San Francisco CA, US
Steven W. Andrews - Longmont CO, US
Kevin R. Condroski - Broomfield CO, US
George A. Doherty - Superior CO, US
Yutong Jiang - Longmont CO, US
John A. Josey - Longmont CO, US
April L. Kennedy - Denver CO, US
Machender R. Madduru - Boulder CO, US
Peter J. Stengel - Longmont CO, US
Steven M. Wenglowsky - Boulder CO, US
Benjamin T. Woodard - Golden CO, US
Laura Woodard - Golden CO, US
Steven W. Andrews - Longmont CO, US
Kevin R. Condroski - Broomfield CO, US
George A. Doherty - Superior CO, US
Yutong Jiang - Longmont CO, US
John A. Josey - Longmont CO, US
April L. Kennedy - Denver CO, US
Machender R. Madduru - Boulder CO, US
Peter J. Stengel - Longmont CO, US
Steven M. Wenglowsky - Boulder CO, US
Benjamin T. Woodard - Golden CO, US
Laura Woodard - Golden CO, US
International Classification:
C07K 5/00
US Classification:
530317
Abstract:
The embodiments provide compounds of the general formulas I-XIX, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating flaviviral infection, including hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.
Novel Macrocyclic Inhibitors Of Hepatitis C Virus Replication
Novel Macrocyclic Inhibitors Of Hepatitis C Virus Replication
US Patent:
2009016, Jul 2, 2009
Filed:
Apr 18, 2008
Appl. No.:
12/106234
Inventors:
Lawrence M Blatt - Brisbane CA, US
Scott D. Seiwert - Pacifica CA, US
Steven W. Andrews - Longmont CO, US
Pierre Martin - Rheinfelden, CH
Andreas Schumacher - Efringen-Kirchen, DE
Bradley Barnett - Northglenn CO, US
C. Todd Eary - Longmont CO, US
Robert Kaus - Longmont CO, US
Timothy Kercher - Boulder CO, US
Weidong Liu - Superior CO, US
Michael Lyon - Superior CO, US
Paul Nichols - Firestone CO, US
Bin Wang - Longmont CO, US
Tarek Sammakia - Boulder CO, US
April Kennedy - Denver CO, US
Yutong Jiang - Longmont CO, US
Scott D. Seiwert - Pacifica CA, US
Steven W. Andrews - Longmont CO, US
Pierre Martin - Rheinfelden, CH
Andreas Schumacher - Efringen-Kirchen, DE
Bradley Barnett - Northglenn CO, US
C. Todd Eary - Longmont CO, US
Robert Kaus - Longmont CO, US
Timothy Kercher - Boulder CO, US
Weidong Liu - Superior CO, US
Michael Lyon - Superior CO, US
Paul Nichols - Firestone CO, US
Bin Wang - Longmont CO, US
Tarek Sammakia - Boulder CO, US
April Kennedy - Denver CO, US
Yutong Jiang - Longmont CO, US
Assignee:
InterMune, Inc. - Brisbane CA
Array BioPharma, Inc. - Boulder CO
Array BioPharma, Inc. - Boulder CO
International Classification:
C07K 5/12, A61K 38/12, A61K 38/21, C12N 9/99, A61P 31/12
US Classification:
424 857, 514 9, 530317, 424 854, 435184
Abstract:
The embodiments provide compounds of the general Formulae I through general Formula VIII, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.
Novel Macrocyclic Inhibitors Of Hepatitis C Virus Replication
Novel Macrocyclic Inhibitors Of Hepatitis C Virus Replication
US Patent:
2009015, Jun 18, 2009
Filed:
May 2, 2008
Appl. No.:
12/114639
Inventors:
LAWRENCE M. BLATT - SAN FRANCISCO CA, US
LIN PAN - SUNNYVALE CA, US
SCOTT SEIWERT - PACIFICA CA, US
PIERRE MARTIN - RHEINFELDEN, CH
ANDREAS SCHUMACHER - EFRINGEN-KIRCHEN, DE
LEONID BEIGELMAN - SAN MATEO CA, US
JYANWEI LIU - SUNNYVALE CA, US
STEVEN W. ANDREWS - LONGMONT CO, US
KEVIN R. CONDROSKI - LAFAYETTE CO, US
YUTONG JIANG - LONGMONT CO, US
ROBERT J. KAUS - LONGMONT CO, US
APRIL L. KENNEDY - DENVER CO, US
TIMOTHY S. KERCHER - BOULDER CO, US
MICHAEL A. LYON - SUPERIOR CO, US
BIN WANG - LONGMONT CO, US
LIN PAN - SUNNYVALE CA, US
SCOTT SEIWERT - PACIFICA CA, US
PIERRE MARTIN - RHEINFELDEN, CH
ANDREAS SCHUMACHER - EFRINGEN-KIRCHEN, DE
LEONID BEIGELMAN - SAN MATEO CA, US
JYANWEI LIU - SUNNYVALE CA, US
STEVEN W. ANDREWS - LONGMONT CO, US
KEVIN R. CONDROSKI - LAFAYETTE CO, US
YUTONG JIANG - LONGMONT CO, US
ROBERT J. KAUS - LONGMONT CO, US
APRIL L. KENNEDY - DENVER CO, US
TIMOTHY S. KERCHER - BOULDER CO, US
MICHAEL A. LYON - SUPERIOR CO, US
BIN WANG - LONGMONT CO, US
International Classification:
A61K 31/407, C07D 487/04, A61K 31/7056, A61K 31/427, A61K 38/21, A61P 31/12
US Classification:
424 855, 548428, 514411, 514 43, 514365, 424 857
Abstract:
The embodiments provide compounds of the general Formula I, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.
Novel Macrocyclic Inhibitors Of Hepatitis C Virus Replication
Novel Macrocyclic Inhibitors Of Hepatitis C Virus Replication
US Patent:
2009014, Jun 11, 2009
Filed:
Jul 17, 2006
Appl. No.:
11/996902
Inventors:
Lawrence M. Blatt - Brisbane CA, US
Scott D. Seiwert - Pacifica CA, US
Steven W. Andrews - Longmont CO, US
Pierre Martin - Rheinfelden, CH
Andreas Schumacher - Efringen-Kirchen, DE
Bradley Barnett - Northglenn CO, US
C. Todd Eary - Longmont CO, US
Robert Kaus - Longmont CO, US
Timothy Kercher - Boulder CO, US
Weidong Liu - Superior CO, US
Michael Lyon - Superior CO, US
Paul Nichols - Firestone CO, US
Bin Wang - Longmont CO, US
Tarek Sammakia - Boulder CO, US
April Kennedy - Denver CO, US
Yutong Jiang - Longmont CO, US
Scott D. Seiwert - Pacifica CA, US
Steven W. Andrews - Longmont CO, US
Pierre Martin - Rheinfelden, CH
Andreas Schumacher - Efringen-Kirchen, DE
Bradley Barnett - Northglenn CO, US
C. Todd Eary - Longmont CO, US
Robert Kaus - Longmont CO, US
Timothy Kercher - Boulder CO, US
Weidong Liu - Superior CO, US
Michael Lyon - Superior CO, US
Paul Nichols - Firestone CO, US
Bin Wang - Longmont CO, US
Tarek Sammakia - Boulder CO, US
April Kennedy - Denver CO, US
Yutong Jiang - Longmont CO, US
Assignee:
Intermune, Inc. - Brisbane CA
Array Biopharma Inc. - Boulder CO
Array Biopharma Inc. - Boulder CO
International Classification:
A61K 38/21, C07K 5/12, A61K 38/12, C07D 209/18, C12N 9/99, A61K 39/395
US Classification:
424 855, 530317, 514 11, 548465, 435184, 4241331, 424 857, 424 854
Abstract:
The embodiments provide compounds of the general Formulae (I) through general Formula (VIII), as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.